Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial

Blonde, L; Rosenstock, J; Del Prato, S; Henry, R; Shehadeh, N; Frias, J; Niemoeller, E; Souhami, E; Li, C; Aroda, VR

Blonde, L (reprint author), Ochsner Med Ctr, Frank Riddick Diabet Inst, Dept Endocrinol, New Orleans, LA 70121 USA.

DIABETES CARE, 2019; 42 (11): 2108

Abstract

OBJECTIVE Fixed-ratio combinations of basal insulin plus glucagon-like peptide 1 receptor agonist (GLP-1 RA) allow concomitant administration of two p......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索